You are here

blood cancers

FDA blocks approval of Regeneron's blood cancer drug over confirmatory trial enrollment

Fierce Biotech

Mon, 03/25/24 - 11:27 am

clinical trials

FDA staff raises concerns over data from J&J, Bristol's CAR-T therapies

Reuters

Wed, 03/13/24 - 10:46 am

Bristol Myers Squibb

Geron faces uphill battle at FDA meeting as agency questions benefit-risk profile of imetelstat

Fierce Biotech

Wed, 03/13/24 - 10:37 am

Gilead Axes Phase III Magrolimab Trial Based on Disappointing Data

BioSpace

Wed, 09/27/23 - 11:12 pm

Gilead Sciences

clinical trials

How Gamida Cell’s FDA Approval Could Reduce Racial Disparities in Stem Cell Transplants

MedCity News

Mon, 04/17/23 - 10:54 pm

BeiGene heaps more pressure on AbbVie, J&J with new Brukinsa head-to-head win over Imbruvica

Fierce Pharma

Wed, 10/12/22 - 11:00 am

Long-Term Data from Omidubicel Phase 3 Trial Demonstrates Overall Survival and Sustainable Durable Outcomes for Patients with Blood Cancers

Businesswire

Thu, 09/29/22 - 09:59 am

FDA's oncology adcomm to review PI3K inhibitors in blood cancers in April

Endpoints

Wed, 03/9/22 - 10:59 am

ASH: Roche's antibody-drug conjugate Polivy added to chemo-antibody combo boosts survival in early-stage lymphoma

Endpoints

Tue, 12/14/21 - 11:12 am

antibody-drug conjugate

What to Expect at ASH: CAR T Results in Lymphoma, Data on IDH1+ AML, and More

OBR Oncology

Wed, 11/24/21 - 10:23 am

FDA approves PharmaEssentia interferon drug for a rare type of blood cancer

MedCity News

Mon, 11/15/21 - 11:44 pm

polycythemia vera

ropeginterferon alfa

Novartis dumps 2nd bispecific from $2.6B Xencor pact, dealing further blow to hopes for blood cancer target

Fierce Biotech

Tue, 11/9/21 - 10:40 am

J&J spends $100M upfront, with $1.2B in biobucks, to join Roche and Regeneron in bispecific blood cancer race

Fierce Biotech

Mon, 10/4/21 - 11:08 am

bispecific antibodies

Imago BioSciences raises $80M to advance blood cancer therapy

Fierce Biotech

Thu, 11/19/20 - 10:20 am

Imago BioSciences

ExCellThera launches trial of drug to expand umbilical cord blood for stem-cell transplants in cancer

Fierce Biotech

Wed, 11/6/19 - 05:16 pm

umbilical cord blood

This Could Be a Big Year for Incyte

Motley Fool

Wed, 09/18/19 - 06:52 pm

ASH18: Argenx pens $1.6B biobucks Janssen pact for blood cancer hopeful cusatuzumab

Fierce Biotech

Mon, 12/3/18 - 09:55 am

Amgen to ramp up early-stage immuno-oncology with 2 MD Anderson deals

Fierce Biotech

Sat, 06/2/18 - 02:33 pm

MD Anderson Cancer Center

drug development

Small-Cell Lung Cancer

AbbVie Expects Imbruvica Revenues to Reach $5 Billion in 2020

Yahoo/Market Realist

Wed, 01/20/16 - 09:27 pm

Epizyme parts ways with its CEO ahead of big Phase II cancer bet

Fierce Biotech

Fri, 08/7/15 - 10:41 am